Utility of Artificial Intelligence in Antibiotic Development: Accelerating Discovery in the Age of Resistance
Antimicrobial resistance (AMR) is a global health concern, causing increased morbidity and mortality. AI can help identify antimicrobial-potent molecules and optimize drug design. This article examines AI’s benefits in antibiotic development, including time, cost, and efficiency, while also discussing challenges in biomedical implementation.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!